2nd Soft Skills Workshop: How to effectively communicate the results of R&D to the professionals and general public
Date and time: 18.11.2024 from 10:00 a.m. to 12:00 p.m.
Format: Online
Workshop language: Slovak
Speaker: Peter Marčan, PR consultant MultiplexDX, agency ReputationN
Description:
This workshop aims to develop researchers' communication skills, with an emphasis on effectively presenting their research results to not only the professional public but also a wider audience. Participants will gain valuable knowledge on strategically setting up and implementing communications through various channels, including media and social networks. In addition, they will learn how to build relationships outside the academic community effectively.
During the workshop, Peter Marčan will share practical experience and useful tips on how to successfully present and disseminate scientific knowledge.
What you will learn:
- How to properly set up a project's communication strategy?
- The importance of a clear message: How to adapt communication to different types of audiences?
- Media versus social networks: Which channels are suitable for different types of communication?
- What makes communication interesting and what to avoid?
We look forward to your participation!
Please register by sending an email to: events@multiplexdx.com
Peter Marčan has been working in the field of PR and marketing since 2008. Among other things, he covered the communication of the Slovak biotech company MultiplexDX, the largest science popularization event in Slovakia - the European Night of Science, as well as other clients working in the field of R&D and innovation. In the past, he worked as an editor for several Slovak media, including the economic weekly TREND.
The Soft Skills program is part of the ADDIT-CE project. The Czech-Slovak consortium and center of excellence aims to develop, validate, and implement modern and innovative diagnostics for Alzheimer's disease. More info about the project https://addit-ce.ceitec.cz
This event has received funding from the European Union’s Horizon Europe program under Grant Agreement No. 101087124. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
About MultiplexDX
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter
